Rocket Lab (RKLB) shares closed at $73.92 on October 2, 2026, after surging nearly 5% on a record 20-mission Electron launch contract with Synspective that lifted the company’s backlog above 100 missions and reinforced multi-year revenue visibility through 2031. Second-quarter results showed revenue of $234 million, up 62% year-over-year, with a $2.36 billion backlog (45% expected within 12 months) and Q3 guidance of $250–265 million. Institutional accumulation by ARK Invest and a fresh Citi Buy rating with a $105 price target have supported sentiment, while the stock trades well below its $151 52-week high amid ongoing Neutron development and the pending Iridium acquisition slated for mid-2027. Next earnings are due November 9.